To

Tolmar

Fort Collins COFounded 20061,000 employees
Private CappharmaPrivateUrologyOncology
Platform: Eligard Prostate
Market Cap
N/A
All Drugs
4
Clinical Trials
6
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (4 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
TOL-8761TOL-8761Phase 22siRNAEGFRJAK1iRBAS
SuranaritideTOL-8762Phase 1/21VaccineC5GLP-1/GIPSMATTR Amyloidosis
VoxainavolisibTOL-2791Preclinical2PeptideBCMAPI3KiSMASCD
SemalemzoparlimabTOL-6648Phase 1/21Gene EditingCD47WEE1iWet AMD
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)
2025-06-13
TOL-8761 Ph2 Data
RB
Past
2026-07-25
Semalemzoparlimab Ph2 Data
Wet AMD
Ph2 Data
2026-10-17
TOL-8761 Conference
MCL
Conference
2027-06-07
Suranaritide Ph2 Data
SMA
Ph2 Data
2027-07-24
TOL-8761 Ph2 Data
MCL
Ph2 Data
2028-10-21
Voxainavolisib Interim
SMA
Interim
2030-12-25
Voxainavolisib Interim
SMA
Interim